NAD Plus Biology: Mechanisms, Research & Clinical Context

Last reviewed: May 31, 2026

Last updated: May 31, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

NAD plus (nicotinamide adenine dinucleotide) is a coenzyme found in every cell, critical for converting nutrients into ATP energy and regulating cellular stress responses. NAD plus levels naturally decline with age, a phenomenon linked to metabolic slowdown and age-related health changes.

Understanding NAD plus biology matters because it connects to how your body manages energy, inflammation, and metabolic efficiency. PlexusDx emphasizes precision wellness—using biomarker context and genetic insights to evaluate whether NAD-focused interventions align with your individual metabolic profile.

How NAD Plus Functions in Cellular Energy Systems

NAD plus acts as an electron shuttle in mitochondria during glycolysis and the citric acid cycle. It accepts and donates electrons, enabling the conversion of glucose and fatty acids into ATP. This fundamental role makes NAD plus availability a bottleneck in energy production efficiency.

Beyond energy, NAD plus regulates sirtuins—proteins that influence DNA repair, inflammation, and longevity pathways. Low NAD plus levels impair these protective mechanisms, contributing to cellular aging and metabolic dysfunction observed in sedentary or high-stress lifestyles.

NAD Plus Depletion: Mechanisms and Risk Factors

NAD plus declines through multiple pathways: increased consumption by stress-response enzymes like PARPs, reduced biosynthesis from tryptophan, and impaired salvage pathways with aging. Studies show NAD plus levels drop approximately 50 percent from age 20 to 60, affecting mitochondrial function.

Factor Contributing to NAD Decline	Mechanism or Evidence
Aging (chronological)	Reduced enzymatic efficiency in NAD biosynthesis and salvage pathways
Chronic inflammation	PARP enzymes consume NAD while repairing stress-induced DNA damage
Sedentary lifestyle	Mitochondrial stress increases NAD demand without adequate production
High-sugar/processed diet	Metabolic stress impairs tryptophan conversion to NAD precursors
Sleep disruption	Circadian dysregulation reduces NAD biosynthesis during overnight repair phases
Oxidative stress exposure	Radiation and environmental toxins increase PARP-mediated NAD consumption

Evidence-Based NAD Restoration Strategies

Preclinical studies show NAD-boosting approaches (NAD precursors like NMN, NR, or direct IV NAD) improve mitochondrial function and metabolic markers in animal models. Human clinical evidence is limited but growing: small trials suggest NAD precursors may support muscle endurance and metabolic flexibility.

Exercise is the most robust NAD-restoring intervention. Resistance and aerobic training increase NAD biosynthesis and sirtuin activation. Dietary factors—niacin, tryptophan-rich foods, caloric restriction—also support NAD pathways, making lifestyle optimization the foundation before considering supplemental interventions.

Biomarkers, Genetics, and Personalized NAD Assessment

NAD plus biomarkers (whole blood or tissue NAD levels) are not yet standardized clinical tests, limiting personalized dosing recommendations. However, indirect markers—circulating lactate, mitochondrial function tests, and NAD-dependent enzyme activity—can provide clinical context for whether NAD restoration aligns with your metabolic state.

Genetic variations in genes encoding NAD biosynthetic enzymes (NAMPT, NMNAT1, PARPs) and in pathways regulating energy metabolism (mitochondrial genes, FTO) influence how efficiently your body produces and preserves NAD. Understanding these predispositions through genetic assessment may help inform whether you are a candidate for targeted NAD interventions. A qualified provider can interpret genetic context alongside biomarker and clinical data to evaluate if NAD-focused strategies match your individual risk profile.

Who Should Discuss NAD Plus Biology With a Provider

NAD restoration strategies are commonly explored by individuals with compromised metabolic health, chronic fatigue, reduced exercise capacity, or metabolic syndrome. Aging adults seeking longevity optimization and those managing high stress or inflammatory conditions often investigate NAD-focused protocols.

Before pursuing NAD supplementation or IV infusions, consult a healthcare provider to evaluate underlying metabolic function, rule out contraindications, and confirm whether NAD restoration is appropriate for your specific health context. Your provider should assess baseline mitochondrial function and whether lifestyle modifications address root causes.

How PlexusDx Supports a More Personalized Approach

PlexusDx uses the Precision Peptide Genetic Test to assess predispositions in metabolic and energy pathway genes. While NAD biology itself is not exclusively a peptide pathway, understanding your genetic profile in GIPR, GLP1R, FTO, and MC4R variants may help provide context on metabolic efficiency and how your body regulates energy—information that can inform discussions about whether NAD restoration complements your broader metabolic wellness strategy.

The Precision Peptide Genetic Test reveals predispositions in genes influencing nutrient utilization and metabolic flexibility. These genetic markers should be interpreted with a qualified healthcare provider to understand how your individual metabolic phenotype may relate to NAD availability and cellular energy efficiency. Genetic predisposition does not predict exact response to any intervention.

If you are exploring NAD plus interventions as part of a comprehensive metabolic approach, your genetic and biomarker context can support a more informed conversation with your provider. PlexusDx recommends integrating genetic insights with direct biomarker assessment and clinical evaluation to design personalized wellness strategies that address your metabolic foundation.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month, or $298 standalone) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $179-$229/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

What is the difference between NAD plus and NAD precursors like NMN and NR?

NAD plus is the active coenzyme; NMN and NR are precursors your cells convert to NAD plus. Precursors may be better absorbed orally, but conversion efficiency varies individually. Direct NAD infusions bypass conversion steps but require clinical administration.

How much does NAD plus decline with age, and when should someone consider restoration?

Studies estimate approximately 50 percent NAD decline from age 20 to 60. Whether and when to pursue restoration depends on your metabolic markers, energy levels, and provider assessment. Lifestyle optimization—exercise, sleep, diet—should precede supplemental interventions.

Does PlexusDx offer NAD plus supplementation or IV infusions?

PlexusDx specializes in compounded GLP-1 medications and the Precision Peptide Genetic Test, which can provide context on your metabolic phenotype. For NAD restoration strategies, consult your healthcare provider about available clinical options in your area.

Are there safety concerns with NAD supplementation or IV infusions?

NAD precursors are generally well-tolerated at recommended doses. IV NAD infusions require medical supervision. Side effects may include flushing, nausea, or headache. Discuss contraindications with your provider, especially if you take medications affecting NAD pathways or have liver disease.

Can the Precision Peptide Genetic Test predict my NAD levels or response to NAD therapies?

The Precision Peptide Genetic Test reveals predispositions in metabolic and energy pathway genes, which may help provide context on your metabolic efficiency. It does not directly predict NAD levels or exact response to NAD interventions. Genetic predisposition should be interpreted with a qualified provider alongside biomarkers and clinical ass...

NAD Plus Biology: Metabolic Pathways and Clinical Evidence for Informed Decisions